Mereo BioPharma Group Plc (MREO)
0.308
0.00 (0.00%)
USD |
NASDAQ |
Oct 19, 15:34
Mereo BioPharma Group Cash from Operations (Annual) : -31.04M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -31.04M |
| December 31, 2024 | -32.85M |
| December 31, 2023 | -21.21M |
| December 31, 2022 | -46.96M |
| December 31, 2021 | -7.204M |
| December 31, 2020 | -40.01M |
| Date | Value |
|---|---|
| December 31, 2019 | -60.33M |
| December 31, 2018 | -32.66M |
| December 31, 2017 | -40.47M |
| December 31, 2016 | -36.46M |
| December 31, 2015 | -10.20M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Biodexa Pharmaceuticals Plc | -7.268M |
| NuCana Plc | -9.377M |
| BioNTech SE | 514.63M |
| Silence Therapeutics Plc | -62.27M |
| Autolus Therapeutics Plc | -284.23M |